The landscape of dementia prognosis has developed considerably with the arrival of innovative biomarkers, like amyloid PET scans, tau imaging, and blood-primarily based tests that can detect Alzheimer's pathology decades in advance of signs or symptoms emerge. While these technological innovations characterize impressive progress in being familiar with neurodegenerative disorders, https://neuropsychologicaltesting23221.look4blog.com/75899214/the-enduring-value-of-cognitive-evaluation-for-older-older-people